Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial

1. Blakemore, S.J.
2. Clifford, R.
3. Parker, H.
4. Antoniou, P.
5. Stec-Dziedzic, E.
6. Larrayoz, M.
7. Davis, Z.
8. Kadalyayil, L.
9. Colins, A.
10. Robbe, P.
11. Vavoulis, D.
12. Forster, J.
13. Carr, L.
14. Morilla, R.
15. Else, M.
16. Bryant, D.
17. McCarthy, H.
18. Walewska, R.J.
19. Steele, A.J.
20. Chan, J.
21. Speight, G.
22. Stankovic, T.
23. Cragg, M.S.
24. Catovsky, D.
25. Oscier, D.G.
26. Rose-Zerilli, M.J.J.
27. Schuh, A.
28. Strefford, J.C.
29. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/S41375-020-0723-2 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus